-
公开(公告)号:US20060030612A1
公开(公告)日:2006-02-09
申请号:US11194263
申请日:2005-08-01
申请人: Robert Steffan , Edward Matelan , Stephen Bowen , John Ullrich , Jay Wrobel , Edouard Zamaratski , Lars Kruger , Annabel Hedemyr , Aiping Cheng , Tomas Hansson , Rayomand Unwalla , Christopher Miller , Patrik Rhonnstad
发明人: Robert Steffan , Edward Matelan , Stephen Bowen , John Ullrich , Jay Wrobel , Edouard Zamaratski , Lars Kruger , Annabel Hedemyr , Aiping Cheng , Tomas Hansson , Rayomand Unwalla , Christopher Miller , Patrik Rhonnstad
IPC分类号: C07D231/56 , A61K31/4162
CPC分类号: C07D403/04 , C07D231/56 , C07D401/04 , C07D401/06 , C07D401/10 , C07D403/10 , C07D405/04 , C07D409/04 , C07D491/10
摘要: This invention provides compounds of Formula (I) or (Ia): that are useful in the treatment or inhibition of LXR mediated diseases.
摘要翻译: 本发明提供式(I)或(Ia)化合物:其可用于治疗或抑制LXR介导的疾病。